# Treatment of Fibromyalgia With the FibroNova Neuromodulation Device

> **NCT06271746** · NA · UNKNOWN · sponsor: **Theranica** · enrollment: 170 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DEVICE:** FibroNova (Active mode)
- **DEVICE:** FibroNova (Sham mode)

## Key facts

- **NCT ID:** NCT06271746
- **Lead sponsor:** Theranica
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-04
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271746, "Treatment of Fibromyalgia With the FibroNova Neuromodulation Device". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06271746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*